Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-055-0 | CAS number: 102-79-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Toxicological Summary
- Administrative data
- Workers - Hazard via inhalation route
- Workers - Hazard via dermal route
- Workers - Hazard for the eyes
- Additional information - workers
- General Population - Hazard via inhalation route
- General Population - Hazard via dermal route
- General Population - Hazard via oral route
- General Population - Hazard for the eyes
- Additional information - General Population
Administrative data
Workers - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 1.58 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- By inhalation
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 75
- Dose descriptor starting point:
- NOAEC
- Value:
- 236.3 mg/m³
- Modified dose descriptor starting point:
- NOAEC
- Value:
- 118.74 mg/m³
- Explanation for the modification of the dose descriptor starting point:
The inhalation rat systemic NOAEC of 236.3 mg/m³ (BASF, 2013) for the nearest analogue Dibutylethanolamine (CAS 102-81-1) served as the starting point for the DNEL derivation. It originated from an inhalative combined Repeated Dose and Reproduction/Developmental Toxicity Screening Test (OECD 422, 413). This is the study with the longest test duration. The NOAEC was converted by considering the exposure duration (6 h/day for rats in the performed study and 8 h for human during one working shift) and the standard respiratory volumes (6.7 m³ for workers under normal condition and 10 m³ under light activity).
236.3 mg/m³ * (6.7 m³/10 m³) * (6h/d / 8h/d) = 118.74 mg/m³
- AF for dose response relationship:
- 1
- Justification:
- clear dose response
- AF for differences in duration of exposure:
- 6
- Justification:
- Default value for time extrapolation from subacute to chronic study
- AF for interspecies differences (allometric scaling):
- 1
- Justification:
- Allometric scaling is not necessary, as no route-to-route extrapolation is applied and doses expressed as concentrations are assumed to be already scaled.
- AF for other interspecies differences:
- 2.5
- Justification:
- default for differences in toxicodynamics
- AF for intraspecies differences:
- 5
- Justification:
- default for workers
- AF for the quality of the whole database:
- 1
- Justification:
- read-across data (substance acts in a similar toxicological pattern)
- AF for remaining uncertainties:
- 1
- Justification:
- No remaining uncertainties have been identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 1.14 mg/m³
- Most sensitive endpoint:
- irritation (respiratory tract)
DNEL related information
- DNEL derivation method:
- other: ECHA REACH Guidance and ECETOC, Technical Report No. 110
- Overall assessment factor (AF):
- 18
- Dose descriptor:
- NOAEC
- AF for dose response relationship:
- 1
- Justification:
- clear dose response
- AF for differences in duration of exposure:
- 6
- Justification:
- Default value for time extrapolation from subacute to chronic study
- AF for interspecies differences (allometric scaling):
- 1
- Justification:
- No allometric scaling in case of local effects
- AF for other interspecies differences:
- 1
- Justification:
- No other differences are identified
- AF for intraspecies differences:
- 3
- Justification:
- As respiratory irritation due to the caustic property of the read-across substance Dibutylaminothanol is the leading effect, no huge differences within humans are expected. Therefore, the AF for worker intraspecies differences was set to 3 as recommended in "Guidance on assessment factors to derive a DNEL", Technical Report No. 110, ECETOC, 2010.
- AF for the quality of the whole database:
- 1
- Justification:
- read-across data (substance acts in a similar toxicological pattern)
- AF for remaining uncertainties:
- 1
- Justification:
- no remaining uncertainties are identified in case of respiratory irritation
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Workers - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 7 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 100
- Dose descriptor starting point:
- NOAEL
- Value:
- 50 mg/kg bw/day
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 700 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
The oral NOAEL of 50 mg/kg bw/day for DBEA (OECD 408; BASF 2020) corrected for differences in experimental exposure conditions: workers (5 working days) vs. rats (7 days continuous exposure) and differences in absorption rates for oral (100 %) and dermal route (10 %)
50 mg/kg bw/d * 7/5 * 100/10 = 700 mg/kg bw/d
- AF for dose response relationship:
- 1
- Justification:
- Clear dose response
- AF for differences in duration of exposure:
- 2
- Justification:
- Default value for time extrapolation from sub-chronic to chronic study
- AF for interspecies differences (allometric scaling):
- 4
- Justification:
- Default for rats
- AF for other interspecies differences:
- 2.5
- Justification:
- Default for toxicodynamics differences
- AF for intraspecies differences:
- 5
- Justification:
- Default for workers
- AF for the quality of the whole database:
- 1
- Justification:
- read-across data (substance acts in a similar toxicological pattern)
- AF for remaining uncertainties:
- 1
- Justification:
- No remaining uncertainties have been identified.
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
Workers - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- medium hazard (no threshold derived)
Additional information - workers
General Population - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.281 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- By inhalation
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 150
- Dose descriptor starting point:
- NOAEC
- Value:
- 236.3 mg/m³
- Modified dose descriptor starting point:
- NOAEC
- Value:
- 42.2 mg/m³
- Explanation for the modification of the dose descriptor starting point:
The inhalation rat systemic NOAEC of 236.3 mg/m³ (BASF, 2013) for the nearest analogue Dibutylethanolamine (CAS 102-81-1) served as the starting point for the DNEL derivation. It originated from an inhalative combined Repeated Dose and Reproduction/Developmental Toxicity Screening Test (OECD 422, 413). The NOAEC was converted by considering the exposure duration (6 h/day and 5 d/week for rats in the performed study and 24 h/day and 7d/week for human).
236.3 mg/m³ * 5/7 * 6/24 = 42.2 mg/m³
- AF for dose response relationship:
- 1
- Justification:
- clear dose response
- AF for differences in duration of exposure:
- 6
- Justification:
- Default value for time extrapolation from subacute to chronic study
- AF for interspecies differences (allometric scaling):
- 1
- Justification:
- Allometric scaling is not necessary, as no route-to-route extrapolation is applied and doses expressed as concentrations are assumed to be already scaled.
- AF for other interspecies differences:
- 2.5
- Justification:
- default for differences in toxicodynamics
- AF for intraspecies differences:
- 10
- Justification:
- default for general population
- AF for the quality of the whole database:
- 1
- Justification:
- read-across data (substance acts in a similar toxicological pattern)
- AF for remaining uncertainties:
- 1
- Justification:
- No remaining uncertainties have been identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.34 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 60
- Dose descriptor:
- NOAEC
- AF for dose response relationship:
- 1
- Justification:
- Clear dose response
- AF for differences in duration of exposure:
- 6
- Justification:
- Default value for time extrapolation from subacute to chronic study
- AF for interspecies differences (allometric scaling):
- 1
- Justification:
- Default in case of local effects
- AF for other interspecies differences:
- 1
- Justification:
- Local effects in respiratory tract of animals and humans have been considered not to depend on toxycodinamics
- AF for intraspecies differences:
- 10
- Justification:
- Default for general population
- AF for the quality of the whole database:
- 1
- Justification:
- Read-across data (substance acts in a similar toxicological pattern)
- AF for remaining uncertainties:
- 1
- Justification:
- No remaining uncertainties have been identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
General Population - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 2.5 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 200
- Dose descriptor starting point:
- NOAEL
- Value:
- 50 mg/kg bw/day
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 500 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
The NOAEL of 50 mg/kg bw/day for DBEA (OECD 408; BASF 2020) is corrected for differences in absorption rats for oral (100 %) and dermal route (10 %)
50 mg/kg bw/d * 100/10 = 500 mg/kg bw/d
- AF for dose response relationship:
- 1
- Justification:
- Clear dose response
- AF for differences in duration of exposure:
- 2
- Justification:
- Default value for time extrapolation from sub-chronic to chronic study
- AF for interspecies differences (allometric scaling):
- 4
- Justification:
- Default for rats
- AF for other interspecies differences:
- 2.5
- Justification:
- Default for toxicodynamics differences
- AF for intraspecies differences:
- 10
- Justification:
- Default for general population
- AF for the quality of the whole database:
- 1
- Justification:
- Read-across data (substance acts in a similar toxicological pattern)
- AF for remaining uncertainties:
- 1
- Justification:
- No remaining uncertainties have been identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
General Population - Hazard via oral route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.25 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 200
- Dose descriptor starting point:
- NOAEL
- Value:
- 50 mg/kg bw/day
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 50 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
The oral NOAEL of 50 mg/kg bw/day for DBEA (OECD 408; BASF 2020) is used as starting point. It does not need to be corrected.
- AF for dose response relationship:
- 1
- Justification:
- Clear dose response
- AF for differences in duration of exposure:
- 2
- Justification:
- Default value for time extrapolation from sub-chronic to chronic study
- AF for interspecies differences (allometric scaling):
- 4
- Justification:
- Default for rats
- AF for other interspecies differences:
- 2.5
- Justification:
- Default for toxicodynamics differences
- AF for intraspecies differences:
- 10
- Justification:
- Default for general population
- AF for the quality of the whole database:
- 1
- Justification:
- Read-across data (substance acts in a similar toxicological pattern)
- AF for remaining uncertainties:
- 1
- Justification:
- No remaining uncertainties have been identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
General Population - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- medium hazard (no threshold derived)
Additional information - General Population
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.